Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have emerged as a standard treatment for various malignancies. However, research indicates blocking the immune checkpoint pathway may exacerbate atherosclerotic lesions. OBJECTIVES: We aimed to investigate whether ICI therapy increases the risk of arte...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jie, Chen, Yue, Zhang, Yuanlong, Wang, Wei, Wang, Yujue, Lu, Zhuo, Zhang, Yulin, Lei, Haike, Li, Dairong, Long, Bo, Liu, Haixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557854/
https://www.ncbi.nlm.nih.gov/pubmed/37584246
http://dx.doi.org/10.1002/cam4.6455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557854/
https://www.ncbi.nlm.nih.gov/pubmed/37584246
http://dx.doi.org/10.1002/cam4.6455

Ejemplares similares